Physician profile
Robert I Levy
NPI 1578506663
$5,030.64
in general payments reported to CMS, 2019-2025
22 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $216 · 2021: $581 · 2022: $1,122 · 2023: $1,354 · 2024: $940 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065 · Entertainment: $262 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.02 |
| Entertainment | $261.89 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,426.27 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $791.97 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $628.05 | 2022-2024 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $267.89 | 2021-2024 | Misight Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Optos, INC. | $261.89 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $239.74 | 2022-2024 | |
| Allergan, INC. | $231.52 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $192.86 | 2021-2024 | Acthar |
| Abbvie INC. | $138.85 | 2023-2024 | |
| Biotissue Holdings INC. | $129.20 | 2023 | |
| Oyster Point Pharma, INC. | $125.01 | 2022 | |
| Horizon Therapeutics Plc | $121.95 | 2022 | |
| Dompe US, INC. | $110.90 | 2023 | Oxervate |
| Lkc Technologies, INC. | $109.73 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.32 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $42.88 | 2019 | |
| Ivantis, INC | $42.08 | 2021 | |
| Maculogix, INC. | $32.15 | 2021 | |
| Abb Con-Cise Optical Group LLC | $25.26 | 2020-2022 | |
| Harrow Eye, LLC | $21.60 | 2024 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $21.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.